Smith & Nephew PLC ADR
Uždarymo kaina
27.6 -0.61
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
27.54
Max
27.98
Pajamos | -29M 303M |
|---|---|
Pardavimai | -106M 3.1B |
P/E Sektoriaus vid. | 19.64 56.597 |
Dividendų pajamingumas | 2.75 |
Pelno marža | 9.784 |
Darbuotojai | 17,000 |
EBITDA | 114M 748M |
Dividendų pajamingumas Sektoriaus vid. | 2.75% 2.18% |
|---|
Rinkos kapitalizacija | -1.4B 12B |
|---|---|
Ankstesnė atidarymo kaina | 28.21 |
Ankstesnė uždarymo kaina | 27.6 |
Smith & Nephew PLC ADR Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
Akcijų palyginimas
Kainos pokytis
Smith & Nephew PLC ADR Prognozė
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$
Apie bendrovę Smith & Nephew PLC ADR
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
